Submitted by Anonymous (not verified) on 20 February 2026 - 9:20
Human medicines European public assessment report (EPAR): Ameluz, 5-aminolevulinic acid hydrochloride, Date of authorisation: 13/12/2011, Revision: 22, Status: Authorised
Source: